is associated with various types of cancer. However, the molecule mechanism of M. hyorhinis infection and its effect on cancer patients' prognosis were unknown. Recently, we reported for the first time that M. hyorhinis infects mammalian cells via the interaction of its membrane protein p37 and the host protein Annexin A2 (ANXA2). And NF-B pathway, a downstream of ANXA2, is activated and mediates M. hyorhinis-driven cell migration. Furthermore, we demonstrated that M. hyorhinis p37 protein expression in gastric cancer tissues positively correlates with tumor metastasis and predicts poor survival. In conclusion, our study uncovers the mechanism by which M. hyorhinis infects mammalian cells and promotes cancer cell migration and unveils the effect of M. hyorhinis infection on gastric cancer survival.
The association of Mycoplasma hyorhinis infection with cancer
Mycoplasmas, a genus of bacteria lacking cell wall, could colonize in host tissues for long time without any pathological effects. Mycoplasma hyorhinis (M. hyorhinis), belonging to mycoplasmas (Class Mollicutes), was first identified in swine in 1962 [1] . It causes respiratory tract infections, arthritis, and inflammation of abdominal cavity in swines [2] . M. hyorhinis is well-known as a common contaminant of cell cultures. The association of M. hyorhinis with human cancers, such as prostate, gastric, colon and ovarian cancer, has been reported in the past three decades [3] [4] [5] . For example, Namiki and colleagues reported the potential of M. hyorhinis infection to elicit malignant transformation of benign human prostate BPH-1 cells in cell culture and xenografts [3] . Additionally, M.
hyorhinis increases the migratory and invasiveness of gastric cancer cells and melanoma cells [5, 6] . In 1980's, Dong and his colleagues generated monoclonal antibody PD4 through immunizing mouse with gastric cancer cell MGC803 [7] . But the subsequent antigen identification work revealed that the molecule recognized by PD4 is a lipoprotein from M. hyorhinis, namely p37, which indicated M. hyorhinis being existed in cancer cells [8] . Using this antibody for immunohistochemistry (IHC), the positive rate was 56% (50/90) in gastric cancer, 28% (18/49) in chronic superficial gastritis, 30% (14/46) in gastric ulcer and 37% (18/49) in intestinal metaplasia [4] . In colon cancer, the positive rate was 55.1% (32/58), but 20.9% (10/49) in adenomarous polyp [4] . These results show a step-wise increase of the positive rate following disease progression.
RESEARCH HIGHLIGHT
To confirm the result of M. hyorhinis infection in cancer tissues, we performed qPCR and IHC with a new cohort of gastric cancer tissues and found that the IHC technique is reliable, whose specificity was 83.0% and the sensitivity was 75.6%. Recently, we found that M. hyorhinis infection positively correlated with blood vessel invasion and metastasis, and the patients infected with M. hyorhinis had a lower 5-year survival rate than that of uninfected patients. However, the association between M. hyorhinis infection and gastric cancer needs to be addressed by multi-centric studies. We also anticipate more interest and the work will be focused on this field in future.
Identification of the microbial and host factors mediating M. hyorhinis infection
Early studies demonstrated p37 as a major component of high-affinity transport system of M. hyorhinis [9, 10] .p37shares partial homology to the hemagglutinin protein of influenza A [11] , but it has no homology to any mammalian proteins. Pro-invasive function of p37 has been documented previously by our lab and others' [11, 12] , but the role of p37 in M. hyorhinis infection is unclear. In the recently published work on journal "Cancer Research", we found that M. hyorhinis could infect both cancerous and noncancerous cells, while cancer cells were more prone to be infected. We also demonstrated that antibody anti-p37 could block the binding of M. hyorhinis to host cells in qPCR, cell ELISA and flow cytometry assays. Furthermore, M. hyorhinis-induced cell migration was also inhibited with the antibody against p37 protein. These results indicate that infection of mammalian cells by M. hyorhinis is p37-dependent. The N-terminal region (amino acids 2-23) of p37 was hydrophobic and has limited homology to proteins of other mycoplasma species [10] . We revealed that the peptide of this region could bind to gastric cancer cells, and blocked M. hyorhinis infection competitively. These results suggest that p37-mediated M. hyorhinis infection rely on its N-terminal region.
In the following work, we identified Annexin A2 (ANXA2) as a protein associated with p37 through their N-terminal region interaction. Using antibody to ANXA2 or small interfering RNA (siRNA) technique, we found that ANXA2 was required for M. hyorhinis infection. These results indicated that ANXA2 is a host receptor mediating M. hyorhinis infection. Several recent studies also reported the relationship between ANXA2 and microbial infection. For example, ANXA2 contributes to HPV16 infection [13] , and is also involved in the formation of hepatitis C virus replication complex on the lipid raft [14] . Our findings demonstrate that ANXA2 contributes to M. hyorhinis infection through its interaction with p37 at their N-termini. Based on this discovering, the N-termini peptides of p37 or ANXA2 may provide therapeutic options to combat M. hyorhinis infection.
Tyr23 phosphorylation of ANXA2 is associated with its membrane localization under stress conditions [15] . We found that M. hyorhinis upregulated Tyr23 phosphorylation of ANXA2 and its membrane recruitment. It was reported that EGFR plays a role in regulating ANXA2 phosphorylation and localization [16] . Moreover, our previous work reported that both M. hyorhinis infection and recombinant p37 treatment could activate EGFR [5, 12] , but the role of EGFR in M. hyorhinis infection and M. hyorhinis-induced metastasis are not fully elucidated. We noticed that ANXA2-EGFR interaction was increased and EGFR preferred to interact with phosphorylated ANXA2 in M. hyorhinis-infected cells. Several recent studies reported that EGFR plays a critical role in pathogen infection. EGFR is a cofactor for HCV entry and is a receptor for HCMV [17, 18] . EGFR and HER2 function together as receptors for C. albicans [19] . Our findings added more evidence for the important role of EGFR in microbial infection.
Signaling pathway mediating M. hyorhinis induced cancer cell migration
We found that NF-B signaling was activated by M. hyorhinis exposure and was required for M. hyorhinis-induced gastric cancer cell migration. Importantly, both ANXA2 and EGFR were upstream of NF-B signaling in the context of M. hyorhinis. Epithelial-mesenchymal transition (EMT) has been recognized as an important step during cancer metastasis [20] . In our another recent study, we observed that M. hyorhinis induced EMT in gastric cancer MGC803, but not in AGS cells, indicating M. hyorhinis' effect on EMT is cell type-dependent for gastric cancer cells [21] . Moreover, molecular markers indicative of EMT was altered upon M. hyorhinis infection in MGC803 cells. We found that these changes were TLR4-and NF-B-dependent. Currently, we are trying to figure out the molecular mechanisms of M. hyorhinis-induced EMT and its contribution to cancer development.
Challenges and Perspectives
Understanding the molecule mechanisms of gastric cancer and identifying the risk factors are important for its prevention and patient-directed therapy. Our recently published work indicates a link between M. hyorhinis infection and the unfavorable outcome of gastric cancer patients. At the molecular level, we uncover the receptor and signaling pathways which mediates M. hyorhinis infection and M. hyorhinis-promoted malignancies. These data will provide several potential approaches for preventing M. hyorhinis infection. However, the role of M. hyorhinis infection in tumorigenesis and the correlated effects of M. hyorhinis and Helicobacter pylori infection in gastric cancer development are unknown. It is very important to elucidate these issues for developing more potential strategies for prevention and treatment of gastric cancer.
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